New York, NY - The use of transesophageal echocardiography (TEE) to guide cardioversion in patients with atrial fibrillation (AF) has taken a step closer to being accepted into medical practice, ...

In the TEE (+) group, LAAT was observed in 26 patients (7.18%). None of the patients had a thromboembolic event within the first month of follow-up. In this observational study, we investigated ...

May 15, 2007 (Denver, CO) - Intracardiac echocardiography (ICE) is about as effective as transesophageal echocardiography (TEE) at assessing thromboembolic risk prior to cardioversion in patients with ...

The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

Cardioversion can improve heart function, reduce the risk of embolism and relieve symptoms in patients with atrial fibrillation. Despite anticoagulation therapy, thromboembolic complications can still ...

Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...

Cardioversion is a medical procedure to correct a heartbeat that is irregular or too fast. It can involve risks and side effects but is generally safe and effective. Doctors primarily use ...